Indeed, a recent study showed that memory impairment in CAA patients with elevated amyloid-PET retention was also associated with increased tau-PET binding and reduced hippocampal volume and the authors suggested that these patients likely have concomitant Tau pathology [40]. The gene discussed is MAPT; the disease is memory impairment.